Aclarion vs BioRestorative Therapies
ACON and BRTX side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACON and BRTX compare
BioRestorative Therapies is the larger company, worth 8.5 times as much as Aclarion ($39.7M against $4.7M).
Aclarion grew revenue faster over the last twelve months (46.0% versus −8.5% for BioRestorative Therapies).
BioRestorative Therapies keeps more of each dollar of sales as profit, with a net margin of −3090% compared with −10260% at Aclarion.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACON | BRTX |
|---|---|---|
| Size and price | ||
| Market cap | $4.7M | $39.7M |
| Share price | $1.63 | $1.56 |
| Change, 1 year | −77.5% | −94.3% |
| Change, 5 years | – | −98.9% |
| Beta (5Y) | 0.77 | 1.08 |
| Employees | 11 | 14 |
| StockData Score | ||
| Total score | 8 | 8 |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 2 |
| Performance score | 0 | 1 (better) |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 47.7× (better) | 111× |
| P/B | 0.3× (better) | 13.1× |
| Growth | ||
| Revenue growth (TTM) | 46.0% (better) | −8.5% |
| Revenue growth, 5Y average | – | 36.1% |
| Profitability | ||
| Gross margin | 29.1% | 92.1% (better) |
| Operating margin | −10789% | −3975% (better) |
| Net margin | −10260% | −3090% (better) |
| Return on equity | −74.1% (better) | −241% |
| Return on invested capital | −959% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 14.17 (better) | 2.35 |
| Altman Z-score | −4.34 (better) | −46.62 |
| Piotroski F-score | 6 (better) | 2 |
| Dividends and buybacks | ||
| Buyback yield | −33.4% | – |
| Shareholder yield | −33.4% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 9.0% | 0.52% |
| Held by insiders | 16.4% | 9.6% |
| Insider net buying, 12 months | $177K | – |
| Short interest, % of float | – | 0.16% |
Go deeper
- ACON stock overview
- ACON income statement
- ACON valuation and score
- BRTX stock overview
- BRTX income statement
- BRTX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.